MHUA
Meihua International Medical Technologies Co Ltd
NASDAQ: MHUA · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$7.61
+0.00% today
Updated 2026-06-03
Market cap
$425.43M
P/E ratio
0.25
P/S ratio
4.75x
EPS (TTM)
$31.00
Dividend yield
—
52W range
$2 – $64
Volume
0.1M
WallStSmart proprietary scores
34
out of 100
Grade: F
Strong Sell
Investment rating
2.0
Growth
F8.5
Quality
A6.0
Profitability
B6.7
Valuation
B2/9
Piotroski F-Score
Weak
5.8
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →199 stocks currently score above 75
Price targets
Analyst target
$6.20
-18.53%
12-Month target
$6.20
-18.53%
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Altman Z 5.83 — safe zone
+ Debt/equity 0.07x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Negative free cash flow $-19.81M
- Revenue declining -16.20% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $104.04M | $103.35M | $97.10M | $96.91M | $89.55M |
| Net income | $19.99M | $6.24M | $11.63M | $10.84M | $3.15M |
| EPS | — | — | — | — | $31.00 |
| Free cash flow | $-904894.00 | $-11.86M | $-2.41M | $14.50M | $-19.81M |
| Profit margin | 19.22% | 6.04% | 11.97% | 11.19% | 10.30% |
Peer comparison
Smart narrative
Meihua International Medical Technologies Co Ltd trades at $7.61. representing a P/E of 0.25x trailing earnings. Our Smart Value Score of 34/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 5.83, it sits in the safe zone. TTM revenue stands at $89.55M. with profit margins at 10.30%.
Frequently asked questions
What is Meihua International Medical Technologies Co Ltd's stock price?
Meihua International Medical Technologies Co Ltd (MHUA) trades at $7.61, on a P/E of 0.3x and a P/S of 4.8x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Meihua International Medical Technologies Co Ltd overvalued?
Meihua International Medical Technologies Co Ltd carries a Smart Value Score of 34/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Meihua International Medical Technologies Co Ltd (MHUA)?
The 12-month analyst consensus target is $6.20, about 18.5% below the current $7.61. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Meihua International Medical Technologies Co Ltd's revenue?
Meihua International Medical Technologies Co Ltd's trailing twelve-month revenue is $89.55M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Meihua International Medical Technologies Co Ltd's Altman Z-Score is 5.83, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio4.75x
ROE8.43%
Beta0.75
50D MA$19.26
200D MA$33.73
Shares out0.06B
Float0.00B
Short ratio—
Avg volume0.1M
Performance
1 week+0.00%
1 month+0.00%
3 months+0.00%
YTD+0.00%
1 year—
3 years—
5 years—